2012-05-14T17:27:30-07:00 2011-06-30 990 2010-07-01 237156071 FRED HUTCHINSON CANCER RESEARCH CENTER FRED 2066674876 1100 Fairview Avenue North Seattle WA 981091024 RANDALL C MAIN 2066674876 2012-05-14 2010 2016-02-24 21:20:13Z Lawrence Corey 1100 Fairview Ave North Seattle WA 98109 567226626 0 X www.fhcrc.org X 1971 WA The mission of the Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death. The Center conducts research of the highest standards to improve prevention and treatment of cancer and related diseases. 20 19 3117 400 -85743 -85743 345330959 388454000 44856905 51692311 4541566 9756524 12787637 20703489 407517067 470606324 62506551 80189368 0 0 205262594 214220175 88717 59204 5599404 120781361 131738614 388639223 426207361 18877844 44398963 555798313 714148481 362793049 461116144 193005264 253032337 The mission of the Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death. The Center conducts research of the highest standards to improve prevention and treatment of cancer and related diseases. 0 0 97970042 17845852 4115055 Program Overview: The Center performs fundamental research in clinical, basic and population science disciplines; exhibits a special competence as a designated research center; serves as a focal point for testing and evaluating outputs of research and development efforts; and couples the outputs of cancer research efforts with medical practice. The Center performs these functions through its five scientific research divisions: Public Health Sciences, Clinical Research, Basic Sciences, Human Biology and Vaccine and Infectious Disease. Public Health Sciences ("PHS") The Division of Public Health Sciences' mission is to identify strategies that will ultimately reduce the incidence of and mortality from cancer and other diseases. PHS faculty focus on determining causes of cancer, helping to identify and assess effective screening and treatment methods, developing prevention strategies that reduce the risk of cancer, and developing research strategies to assist people to change behaviors toward healthier lifestyles. This prevention-oriented research also extends to other diseases, including HIV/AIDS, cardiovascular disease, diabetes, and fractures. The Division of Public Health Sciences is home to the nation's oldest and largest program devoted to cancer-prevention research-an important endeavor, considering that many cancers may be avoidable by changes in lifestyle. The PHS Division is organized into six administrative programs. Each of these programs has a faculty with a wide range of interests and an interactive and interdisciplinary research orientation. These programs are as follows: Biostatistics and Biomathematics - The Biostatistics & Biomathematics Program provides statistical collaboration and coordination for research programs within and outside the center, develops and evaluates new quantitative methods for the efficient design and analysis of a broad range of biomedical studies and constructs biomathematical models of carcinogenesis and other biological processes. Cancer Biology - The Cancer Biology Program applies molecular biology, genetics, pathology, epidemiology, and biostatistics to studies of human populations, focusing on the root causes of cancer. Cancer Prevention - The Cancer Prevention Program uses interdisciplinary approaches to evaluate the causes, detection and control of cancer in laboratory, clinic and community-based studies. Computational Biology - Scientists within the Computational Biology Program use and develop computational methods and tools to address biological questions. The Program encompasses a wide range of bioinformatic and computational approaches. Epidemiology - The Epidemiology Program seeks to determine the causes of cancers through studies in human populations of personal exposures, behavioral characteristics, and genes that may influence a person's chances of developing one or more cancers. Molecular Diagnostics - The Molecular Diagnostics Program works to discover accurate methods for determining an individual's cancer risk; detecting cancer at its earliest, most curable stage; classifying the type and extent of cancer, once diagnosed; and monitoring response to therapy and disease progression. 86645261 8886306 13263449 Clinical Research Division: From laboratory bench to bedside, the Clinical Research Division works to develop and analyze new treatments for cancers and other diseases. Researchers seek new or improved ways to cure cancer. Foremost among their contributions has been the development of bone marrow transplantation, a technique that is now saving tens of thousands of lives worldwide annually. In 1990, Dr. E. Donnall Thomas, director emeritus of the Clinical Research Division, received the Nobel Prize in physiology or medicine for his pioneering work developing this technique. Through clinical research, Center scientists continue to refine the techniques of transplantation and extend its use. Once exclusively used for treatment of leukemia, lymphomas and similar diseases, bone marrow transplantation is now being successfully applied to a growing number of diseases, including breast, ovarian and kidney cancer, sickle cell disease and autoimmune disorders such as multiple sclerosis and scleroderma. Other avenues of research being conducted in the Clinical Research Division include immunotherapy, antibody therapy and cancer vaccines. Approximately 450 patients from all over the world receive transplants at the Seattle Cancer Care Alliance coordinated by researchers from the Center's Bone Marrow Transplant Program. The Seattle Cancer Care Alliance, established in 1998, unites the adult and pediatric cancer-care services of the Hutchinson Center, UW Medicine and Seattle Children's. A major focus of SCCA is to speed the transfer of new diagnostic and treatment techniques from the research setting to the patient bedside while providing premier, patient-focused cancer care. Thousands of other cancer patients will be able to receive similar treatment in their local hospitals as a result of the knowledge shared by Clinical Research Division scientists with physicians around the world. Because of the Center's training efforts, many hospitals throughout the United States now perform bone marrow transplants. Scientists in the Center's Clinical Research Division have recorded several "firsts" in cancer research and treatment: * Showing that patients with acute leukemia who have failed chemotherapy can be cured with bone marrow transplantation. * Showing that bone marrow transplantation is the best form of initial therapy for patients with acute myelogenous leukemia, a disease that affects approximately 15,000 Americans each year. * Showing that bone marrow transplantation can cure chronic myelogenous leukemia, a disease that is otherwise incurable and affects approximately 3,000 Americans each year. * Developing the first FDA-approved antibody-targeted chemotherapy, making chemotherapy less toxic and more effective. * Pioneering the first antibody-targeted therapy against a marker specific to non-Hodgkins lymphoma, an approach now used to treat thousands of people each year. * Developing a "tumor paint" that will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells. The tumor paint, derived from scorpion venom, was developed in collaboration with researchers at Seattle Children's Hospital Research Institute. The high quality of the research conducted in the Center's Clinical Research Division is matched only by the quality of care provided to patients receiving treatment. 120336383 43937224 5054513 Vaccine and Infectious Disease Division ("VIDD") The Vaccine and Infectious Disease Division (VIDD) scientists integrate clinical care, computational methods and basic science research to reduce the global burden of infectious disease. VIDD has over 50 faculty members who specialize in a range of disciplines that synergize and complement one another. Administratively, VIDD also encompasses major networks and service programs as well as clinical consulting services in infectious diseases. The multidisciplinary nature of VIDD's faculty and services provide a robust and cohesive scientific community. VIDD research programs integrate the latest in computational, laboratory and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. VIDD researchers partner with scientists at laboratory, clinical and field sites in Africa, Asia and Europe. The Division has specific initiatives in Uganda, China and the Republic of South Africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions. VIDD scientists around the world including clinicians, clinical trials specialists, statisticians, computational biologists and basic scientists take pride in their collaborative efforts to predict, detect, treat and prevent infectious diseases in humans. 97769315 9519986 29259294 (Expenses $97,769,315 including grants of $9,519,986) (Revenue $29,259,294) 97769315 9519986 29259294 402721001 1 1 0 1 0 0 0 1 0 1 1 1 1 0 1 0 1 0 0 0 1 1 1 1 1 0 0 1 0 1 1 0 1 0 0 0 0 0 0 1 1 1 0 0 0 0 1 1 1 0 0 1 0 0 3117 1 1 1 1 CJ UK 0 0 0 1 1 0 0 0 0 0 X 20 19 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CO CT FL GA HI IL KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV X Fred Hutchinson Cancer Research Center Randy Main 2066674876 1100 Fairview Ave North J6-300 Seattle WA 98109 Douglas Walker 5 X 0 0 0 Steve Davis 5 X 0 0 0 Richard Anderson 2 X 0 0 0 Hollis Dillon 2 X 0 0 0 Karl Ege 6 X 0 0 0 Karen Glover 3 X 0 0 0 Ronald Howell 2 X 0 0 0 Peter Horvitz 1 X 0 0 0 Don Listwin 1 X 0 0 0 Richard McCune 1 X 0 0 0 Karen Moyer 1 X 0 0 0 Sally Narodick 2 X 0 0 0 Robert Nelson 1 X 0 0 0 Peter Neupert 1 X 0 0 0 Charles Nolan 1 X 0 0 0 James Sinegal 2 X 0 0 0 Stephen Sundborg 1 X 0 0 0 Vijay Vashee 2 X 0 0 0 Douglas Williams 2 X 0 0 0 Stephen Graham 2 X 0 0 0 Lawrence Corey 9 X 125802 0 0 Leland H Hartwell 40 X 592890 0 41293 Frederick R Appelbaum 40 X 588354 0 43686 Janell E Baldwin 40 X 202337 0 32522 Anthony Bozzuti 40 X 255756 0 16074 Jonathan Cooper 40 X 262763 0 38493 Linda L Gainer 40 X 246720 0 43292 Mark T Groudine 40 X 468180 0 61056 Randall C Main 40 X 368324 0 44556 Margaret Juliana McElrath 40 X 232458 0 59191 Ulrich W Mueller 40 X 252869 0 47322 Howard Albert Nachtrieb 40 X 242965 0 47250 Ross L Prentice 40 X 399255 0 44538 Scott N Rusch 40 X 201776 0 38218 Douglas J Shaeffer 40 X 319538 0 44807 Myra H Tanita 40 X 473212 0 45780 Barbara Trask 40 X 284882 0 56778 Steven G Self 40 X 281222 0 67642 Irwin D Bernstein 40 X 295080 0 59165 Martin A Cheever 40 X 288162 0 56695 Samir M Hanash 40 X 328794 0 43254 Charles N Petty 40 X 262694 0 36995 Henry F Warden 40 X 261812 0 39064 F Marc Stewart 40 X 197371 0 37179 Rainier F Storb 40 X 247218 0 57436 James M Roberts 40 X 148155 0 35145 7828589 0 1137431 318 1 1 0 Seattle Cancer Care Alliance 825 Eastlake Ave E Seattle WA 98109 Patient care services 3520670 Metropolitan Building Maintenance Co 3829 Aurora Ave N Seattle WA 98103 Maintenance services 1319794 JP Morgan Chase Bank NA 1111 Polaris Parkway Columbus OH 43240 Letter of Credit fees 1155929 McKinsey and Company Inc 55 E 52nd St New York NY 10022 Consulting services 1134900 Bank of America 401 N Tryon St Charlotte NC 28255 Letter of Credit fees 1060776 48 658821 0 7416286 0 319314618 61064275 6442158 388454000 Research Activities 900099 12808946 12808946 0 0 Interaffiliate Agreements & Services 900099 29259294 29259294 0 0 Patient Services at SCCA 900099 9624071 9624071 0 0 0 0 0 0 51692311 3266921 0 -85743 3352664 202743 0 0 202743 18424245 0 0 18424245 2738491 0 0 0 2738491 0 2738491 0 0 2738491 101879000 48250 95640390 0 6238610 48250 6286860 0 0 6286860 520665 7416286 979912 -459247 0 -459247 0 0 0 0 0 0 0 0 0 0 0 0 0 470606324 51692311 -85743 30545756 73784560 73784560 0 0 6404808 6404808 0 0 6653495 3467460 3186035 0 0 0 0 0 164643143 134035564 27477701 3129878 11199185 9187601 1805412 206172 19799988 16161394 3278870 359724 11924364 9608576 2105449 210339 0 0 0 0 1513271 7012 1506259 0 257995 0 257995 0 118859 0 118859 0 59204 59204 1032945 0 1032945 0 22522933 11939125 10189026 394782 392762 0 323827 68935 4176956 1042828 2563387 570741 1044952 0 1044952 0 0 0 0 0 6882880 117312 6765568 0 2592397 2151648 319382 121367 0 0 0 0 555092 477920 59943 17229 13511373 12565577 945796 0 0 0 0 0 25147092 22158566 2988526 0 1573949 0 1573949 0 Research supplies 25494490 25494490 0 0 Equipment rental & maintenance 13419604 2338943 11035955 44706 Allocation of indirect costs 0 63383467 -63383467 0 11501064 8394150 2690587 416327 426207361 402721001 17886956 5599404 15274 9037 35926246 61510742 32217752 34026493 18479708 18046009 695757 621757 1164713 1446837 626737871 301381978 265178985 325355893 58983024 125674643 48090908 40827536 59784031 71213967 0 35261915 35415567 555798313 714148481 38025954 35760069 0 0 29178432 26711012 266607522 372159052 0 0 0 0 0 0 0 0 28981141 26486011 362793049 461116144 X 114011264 162996337 32312000 38223000 46682000 51813000 193005264 253032337 555798313 714148481 X 44398963 15628110 X 0 1 1 X 1 1 X 301287235 322118651 309139679 345010973 387997752 1665554290 0 0 0 0 0 0 0 0 0 0 0 0 301287235 322118651 309139679 345010973 387997752 1665554290 0 1665554290 19279966 20511518 6696878 17583481 30871010 94942853 0 18779 -38843 -62064 -85743 -167871 0 0 0 0 0 0 1760329272 0 0.94616 0.95228 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 118859 118859 425055557 425174416 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 118116 106714 112213 118859 455902 250000 250000 250000 250000 1000000 1500000 0 0 0 0 0 0 710646 0 0 X X Per Donor Restriction, must maintain until 2030 0 82001707 14234000 14988000 0 16994000 0 94229707 75830000 5559524 7831043 0 7218860 0 82001707 100751000 4053000 -18913000 0 10061000 0 75830000 0.68 0.26 0.06 0 0 0 52389138 52389138 0 376821746 217559101 159262645 0 0 0 0 0 164346906 83822877 80524029 0 33180081 0 33180081 325355893 Mortgage-Backed Securities 1868768 F Collaterized Mortgage Oblig 371278 F Asset Backed Securities 195060 F Hedge Funds 4736728 F Limited Partnerships 22991634 F Ikaria Stock 9837185 F Other 826883 F 40827536 Investment in Seattle Cancer Care Alliance 71213967 C 71213967 Beneficial Interest in Perpetual Trusts 27330741 Rental Property 5555444 Deferred Financing Costs 2530782 Others -1400 35415567 Deferred Credit Cash Flow Hedge 26486011 26486011 470606324 426207361 44398963 13133181 0 0 0 2494930 15628111 60027074 469573378 0 0 0 0 0 469573378 1032946 0 1032946 470606324 425174416 0 0 0 0 0 425174416 1032945 0 1032945 426207361 SchD_P03_S00_L04 Schedule D, Part III, Line 4 In January 2010, the QTIP Trust of the 1993 Kullman Family Trust donated to the Center a collection of forty black and white photographs which had an appraised value of $710,646 at the time of the donation. The Artwork Donation Agreement requires the Center to display the Artwork as a collection at its main campus in Seattle, Washington for at least twenty years. The Artwork Donation Agreement states that "the Center shall have the right to use and display the Artwork in the manner that best serves the interest of the Center." At the end of the required twenty year display period, the Center will determine if opportunities exist that may allow the value of the donated artwork to fund the Center's research. SchD_P05_S00_L04 Schedule D, Part V, Line 4 Spending Policy - The Center's spending policy for endowment funds is to appropriate for distribution each year 5% percent of the endowment fund's average fair value over the prior three years, provided that the fair value of the endowment fund exceeds the corpus. For a portion of the Center's Board-designated investments, the Center does not appropriate for distribution any amount of investment return as all of the return earned is held to grow the fund for future repayment of long-term debt. For the remaining board designated investments, the Center makes all investment return available for expenditure on programmatic initiatives. In establishing these policies, the Center considered the long-term expected returns on its endowment and Board-designated investments. SchD_P11_S00_L08 Schedule D, Part XI, Line 8 Change in net unrealized fair value of swap instruments. 1 Central America and the Caribbean 0 0 Grantmaking N/A 719111 East Asia and the Pacific 0 0 Grantmaking N/A 142614 Europe (including Iceland and Greenland) 0 0 Grantmaking N/A 1550858 North America (including Canada and Mexico, but not the United States) 0 0 Grantmaking N/A 850758 South America 0 0 Grantmaking N/A 521874 Sub-Saharan Africa 0 0 Grantmaking N/A 1989083 Sub-Saharan Africa 0 1 Program Services Research 71427 0 1 5845725 Central America and the Caribbean LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 566941 Wire transfer 0 N/A N/A Central America and the Caribbean LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 152170 Wire transfer 0 N/A N/A East Asia and the Pacific BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI 142614 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI 23052 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI 9609 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR 186153 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) HVTN LABORATORY PROGRAM 169981 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: HIV PR 150036 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 682561 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) MODELING PROSTATE CANCER CONTROL: PREVENTION, SCREENING, 197807 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) THE PATHOGENESIS OF FMD: FACIOSCAPULOHUMERAL MUSCULAR 105504 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI 26156 Wire transfer 0 N/A N/A North America (including Canada and Mexico, but not the United States) BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI 57918 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA 38246 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN 167485 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) HVTN LABORATORY PROGRAM 14173 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) THE GENETICS OF PARALLEL REPRODUCTIVE ISOLATION IN STICK 30722 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) THE PACIFIC NORTHWEST PROSTATE CANCER SPORE 307340 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) THE STATISTICAL AND COMPUTATIONAL ANALYSIS OF FLOW CYTOM 82994 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) TREC: MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION 7402 Check 0 N/A N/A North America (including Canada and Mexico, but not the United States) WASHINGTON VACCINE ALLIANCE 144477 Check 0 N/A N/A South America BREAST HEALTH GLOBAL INITIATIVE 21400 Wire transfer 0 N/A N/A South America IMPROVING BREAST CANCER SCREENING AT THE PRIMARY CARE LE 17246 Wire transfer 0 N/A N/A South America LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 279649 Wire transfer 0 N/A N/A South America READINESS ASSESSMENT FOR IMPLEMENTATION OF BREAST CANCER 5376 Wire transfer 0 N/A N/A South America LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 198203 Wire transfer 0 N/A N/A Sub-Saharan Africa EARLY AND REINFECTION IN HIGH RISK WOMEN 43111 Wire transfer 0 N/A N/A Sub-Saharan Africa HVTN LABORATORY PROGRAM 248294 Wire transfer 0 N/A N/A Sub-Saharan Africa HVTN LABORATORY PROGRAM 594430 Wire transfer 0 N/A N/A Sub-Saharan Africa LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 45946 Check 0 N/A N/A Sub-Saharan Africa LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 193577 Wire transfer 0 N/A N/A Sub-Saharan Africa LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 351175 Wire transfer 0 N/A N/A Sub-Saharan Africa LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 13500 Wire transfer 0 N/A N/A Sub-Saharan Africa LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 5037 Wire transfer 0 N/A N/A Sub-Saharan Africa LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL 418842 Wire transfer 0 N/A N/A Sub-Saharan Africa ADULT LEUKEMIA RESEARCH CENTER 22150 Wire transfer 0 N/A N/A Sub-Saharan Africa IMPACT OF HIV AND HHV-8 CO-INFECTION ON ANTIRETROVIRAL T 33921 Wire transfer 0 N/A N/A Sub-Saharan Africa ASSOCIATION BETWEEEN HIV AND SURVIVAL AFTER CANCER DIAGN 15006 Wire transfer 0 N/A N/A 1 29 Airfare Central America and the Caribbean 1 1093 Check 0 N/A N/A Airfare East Asia and the Pacific 1 101423 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) East Asia and the Pacific 1 26030 Check 0 N/A N/A Airfare Europe (including Iceland and Greenland) 1 121277 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) Europe (including Iceland and Greenland) 1 39425 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) Europe (including Iceland and Greenland) 1 2222 Wire 0 N/A N/A Airfare Middle East and North Africa 1 2110 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) Middle East and North Africa 1 526 Check 0 N/A N/A Airfare North America (including Canada and Mexico, but not the United States) 1 16923 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) North America (including Canada and Mexico, but not the United States) 1 4693 Check 0 N/A N/A Airfare Russia and the newly independent States 1 13777 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) Russia and the newly independent States 1 10684 Check 0 N/A N/A Airfare South America 1 22519 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) South America 1 2531 Check 0 N/A N/A Airfare South Asia 1 4330 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) South Asia 1 360 Check 0 N/A N/A Airfare Sub-Saharan Africa 1 166160 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) Sub-Saharan Africa 1 22086 Check 0 N/A N/A Travel costs (e.g. lodging, meals, incidentals, etc.) Sub-Saharan Africa 1 914 Wire 0 N/A N/A 0 0 0 0 0 0 SchF_P01_S00_L02 Schedule F, Part I, Line 2 Procedure for Monitoring the Use of Grant Funds Once the notice of award has been received and the Center project ID activated, the subaward can be set up. The structure of the subaward will depend on how the Prime is set up. Generally at the Center, a new PO is requisitioned for each subaward for each year of a project. This allows the RC to closely monitor subaward invoices and encumbrances. For our Subrecipients, it means a separate budget ID and final invoice each year. Carryover between years is not automatic. There are 5 primary steps. 1) Step one is within OSR. The Grant Specialist notifies the Contract Specialist that a grant which includes a subaward has been funded, and provides to the Contract Specialist a copy of the award, the signed subaward application (if available) and any special instructions. A signed subaward application is important because it shows that the Subrecipient organization has reviewed and approved the budget and scope of work. 2) The Research Coordinator (RC) sends the Contract Specialist a Subcontract Acquisition Form (SAF). This form provides authorization for the Contract Specialist to issue the subaward, and included a scope of work, budget and pertinent subrecipient information. It is necessary to provide the scope of work and budget on the SAF as these items may have changed from what was originally submitted in the subaward application. 3) The Contract Specialist requisitions the subaward PO, which the RC must approve. An e-mail is sent to the RC notifying them that the requisition is pending and requires approval. Because OSR does not have funds commitment authority the RC is required to approve all requisition. 4) OSR collects information required to correctly set up the subaward. These items include IRO and IACUC approval dates, confirmation of subaward F&A rates and A-133 Audit reports, review of Prime special terms and conditions to determine flow-down, confirmation that the Subrecipients is not debarred, and other similar regulatory and administrative requirements. While much of this information is collected by OSR, the RC may, in addition to completing the SAF, be asked to assist in the collection of some of the documentation. 5) OSR writes the subaward agreement, and mails it to the Subrecipients for signature. Some agreements can be signed by OSR before mailing, while others will be sent unsigned. This is determined by the Contract Specialist based on the terms of award and status of administrative and regulatory requirements. A copy of the initial subaward is sent to the RC. Once the subaward has been fully signed, a copy is sent to the RC for their files. No invoices should be approved by the RC until they have received a fully executed agreement. SchF_P04_S00_L00 Schedule F, Part IV Schedule F, Part III, Number of Recipients - The data presented above are employee incurred foreign travel costs which we believe meet the IRS Schedule F, Part III's request for grants and other assistance to "U.S. individuals for foreign activity." As such, column (c)'s request for "the number of recipients that received the type of assistance in that region" does not appear to apply foreign travel cost incurred by U.S. individuals. X X X X X X 1 Lewis Kennedy Associates Inc PO Box 3257 Portland OR 97208 Direct Mail 0 600983 59204 541779 600983 59204 541779 AK AL AR AZ CA CO CT FL GA HI IL KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV Hutch Holiday Gala 6131259 5798259 333000 0 0 0 193881 33123 195027 Climb to Fight Breast Cancer 459796 459796 0 0 0 0 0 0 309833 7 1345896 1158231 187665 0 0 0 87728 26186 134135 7936951 7416286 520665 0 0 0 281609 59309 638995 979913 -459248 1 ADMINISTRATORS OF THE TULANE 800 EAST COMMERCE RD SUITE 203 HARAHAN LA 70123 720423889 501(c)(3) 62631 0 N/A N/A HVTN LABORATORY PROGRAM AIDS RESEARCH ALLIANCE OF AMERICA 1400 S GRAND AVE SUITE 701 LOS ANGELES CA 90015 954264845 501(c)(3) 988421 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL BATTELLE MEMORIAL INSTITUTE ATTN CASHIER P O BOX 84262 SEATTLE WA 981245562 314379427 501(c)(3) 49042 0 N/A N/A RADIATION DOSE-DEPENDENT INTERVENTIONS BATTELLE MEMORIAL INSTITUTE ATTN CASHIER P O BOX 84262 SEATTLE WA 981245562 314379427 501(c)(3) 719398 0 N/A N/A IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD BATTELLE MEMORIAL INSTITUTE ATTN CASHIER P O BOX 84262 SEATTLE WA 981245562 314379427 501(c)(3) 8791 0 N/A N/A BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM - SUPPLEMEN BATTELLE MEMORIAL INSTITUTE ATTN CASHIER P O BOX 84262 SEATTLE WA 981245562 314379427 501(c)(3) 62791 0 N/A N/A THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM- PHASE BAYLOR COLLEGE OF MEDICINE BCM280 ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 501(c)(3) 732992 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL BAYLOR COLLEGE OF MEDICINE OFFICE OF GRANTS & CONTRACTS BCM 206 ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 501(c)(3) 31613 0 N/A N/A CORE ASSAYS MRLI - W1 W3 BAYSTATE MEDICAL CENTER INC P O BOX 414168 BOSTON MA 022414168 042790311 501(c)(3) 14700 0 N/A N/A A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L BECKMAN RESEARCH INSTITUTE OF THE 1500 EAST DUARTE ROAD DUARTE CA 910103012 953432210 501(c)(3) 18054 0 N/A N/A BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI BECKMAN RESEARCH INSTITUTE OF THE 1500 EAST DUARTE ROAD DUARTE CA 910103012 953432210 501(c)(3) 14074 0 N/A N/A TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMOR BENAROYA RESEARCH INSTITUTE 1201 NINTH AVE SEATTLE WA 98101 910653422 501(c)(3) 89657 0 N/A N/A MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS BENAROYA RESEARCH INSTITUTE 1201 NINTH AVE SEATTLE WA 98101 910653422 501(c)(3) 42099 0 N/A N/A HEMATOPOIETIC CELL TRANSPLANTATION AND IRON OVERLOAD BETH ISRAEL DEACONESS MEDICAL CENTER RESEARCH FINANCE OFFICE BR 109 330 BROOKLINE AVENUE ROOM 262 BOSTON MA 02215 042103881 501(c)(3) 48998 0 N/A N/A HVTN LABORATORY PROGRAM BOARD OF TRUSTEES OF THE LELAND P O BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(c)(3) 55407 0 N/A N/A IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD BOARD OF TRUSTEES OF THE LELAND P O BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(c)(3) 10191 0 N/A N/A STATISTICAL METHODS FOR INTEGRATIVE ANALYSIS OF GENOMICS BOARD OF TRUSTEES OF THE LELAND P O BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(c)(3) 74861 0 N/A N/A IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC BOARD OF TRUSTEES OF THE LELAND P O BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(c)(3) 126914 0 N/A N/A PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM BOARD OF TRUSTEES OF THE LELAND P O BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(c)(3) 149586 0 N/A N/A CANCER CENTER SUPPORT GRANT (COMPREHENSIVE) BOARD OF TRUSTEES UNIVERSITY OF ILLINOIS GRANTS & CONTRACTS P O BOX 20787 SPRINGFIELD IL 627080787 376000511 University 8615 0 N/A N/A HVTN LABORATORY PROGRAM BOARD OF TRUSTEES UNIVERSITY OF ILLINOIS GRANTS & CONTRACTS P O BOX 20787 SPRINGFIELD IL 627080787 376000511 University 1146649 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL BRIGHAM AND WOMENS HOSPITAL INC BANK OF AMERICA NA P O BOX 3887 FINANCE BOSTON MA 022413887 042312909 501(c)(3) 947595 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL BRIGHAM AND WOMENS HOSPITAL INC BANK OF AMERICA NA P O BOX 3887 FINANCE BOSTON MA 022413887 042312909 501(c)(3) 118798 0 N/A N/A BIOCONDUCTOR- AN OPEN COMPUTING RESOURCE FOR GENOMICS BRIGHAM AND WOMENS HOSPITAL INC BANK OF AMERICA NA P O BOX 3887 FINANCE BOSTON MA 022413887 042312909 501(c)(3) 76069 0 N/A N/A BARRETT'S ESOPHAGUS- PREDICTORS OF PROGRESSION BRIGHAM AND WOMENS HOSPITAL INC BANK OF AMERICA NA P O BOX 3887 FINANCE BOSTON MA 022413887 042312909 501(c)(3) 176148 0 N/A N/A COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR BRIGHAM AND WOMENS HOSPITAL INC BANK OF AMERICA NA P O BOX 3887 FINANCE BOSTON MA 022413887 042312909 501(c)(3) 1061377 0 N/A N/A GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C BROAD INSTITUTE INC CASH MANAGER 7 CAMBRIDGE CENTER OFFICE 7112L CAMBRIDGE MA 02142 263428781 501(c)(3) 998654 0 N/A N/A IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD BROAD INSTITUTE INC ATTN AMY GALAVIZ 7 CAMBRIDGE CENTER CAMBRIDGE MA 02142 263428781 501(c)(3) 681793 0 N/A N/A MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C BROAD INSTITUTE INC CASH MANAGER 7 CAMBRIDGE CENTER OFFICE 7112L CAMBRIDGE MA 02142 263428781 501(c)(3) 1095058 0 N/A N/A GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C BROAD INSTITUTE INC CASH MANAGER 7 CAMBRIDGE CENTER OFFICE 7112L CAMBRIDGE MA 02142 263428781 501(c)(3) 36585 0 N/A N/A BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM - SUPPLEMEN BROAD INSTITUTE INC CASH MANAGER 7 CAMBRIDGE CENTER OFFICE 7112L CAMBRIDGE MA 02142 263428781 501(c)(3) 248585 0 N/A N/A THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM- PHASE CALIFORNIA RURAL INDIAN HEALTH BOARD INC 4400 AUBURN BLVD 2ND FLOOR SACRAMENTO CA 95841 237052541 501(c)(3) 49485 0 N/A N/A A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON CANCER RESEARCH AND BIOSTATISTICS 1730 MINOR AVENUE SUITE 1900 SEATTLE WA 981011468 911828539 501(c)(3) 2681979 0 N/A N/A SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER CANCER RESEARCH AND BIOSTATISTICS 1730 MINOR AVENUE SUITE 1900 SEATTLE WA 981011468 911828539 501(c)(3) 151771 0 N/A N/A CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER CASE WESTERN RESERVE UNIVERSITY OFFICE OF SPONSORED PROJECTS ACCOUNTING 10900 EUCLID AVE CLEVELAND OH 441067037 341018992 501(c)(3) 207949 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL CASE WESTERN RESERVE UNIVERSITY OFFICE OF SPONSORED PROJECTS ACCOUNTING 10900 EUCLID AVE CLEVELAND OH 441067037 341018992 501(c)(3) 114325 0 N/A N/A IDENTIFY AND VALIDATE NOVEL EPIGENETIC MOLECULAR MARKERS CEDARS SINAI MEDICAL CENTER SPONSORED RESEARCH & FUNDS ADMINISTRATION 8700 BEVERLY BLVD SUITE 1150 65-WIL LOS ANGELES CA 900481865 951644600 501(c)(3) 97555 0 N/A N/A PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM CENTER FOR MEDICAL TECHNOLOGY POLICY WORLD TRADE CENTER BALTIMORE 401 EAST PRATT STREET SUITE 631 BALTIMORE MD 21202 261409553 501(c)(3) 252366 0 N/A N/A CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER CHILDREN'S HOSPITAL MEDICAL CENTER DBA ACCOUNTING OFFICE MLC-5000 3333 BURNET AVENUE CINCINNATI OH 452293039 310833936 501(c)(3) 114764 0 N/A N/A DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIE CITY AND COUNTY OF SAN FRANCISCO 1380 HOWARD ST RM 417 SAN FRANCISCO CA 94103 946000417 CITY-CNTY OF SF 296975 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL CITY OF PHILADELPHIA 1401 JFK BLVD ROOM 1380 MSB PHILADELPHIA PA 19102 236003047 CITY OF PHILADELPHIA 62443 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR CLINICAL ALLIANCE FOR RESEARCH AND 3289 WOODBURN ROAD SUITE 250 ANNANDALE VA 22003 202651141 178847 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL COLORADO STATE UNIVERSITY CASHIER'S OFFICE 6015 CAMPUS DELIVERY - OSP FORT COLLINS CO 805236015 846000545 University 146595 0 N/A N/A TREC- MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION COMSYS INFO TECHNOLOGY SERVICES LLC P O BOX 60260 CHARLOTTE NC 28260 751300240 212450 0 N/A N/A CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT CORNELL UNIVERSITY P O BOX 22 ITHACA NY 148510022 150532082 501(c)(3) 129829 0 N/A N/A TOWARDS A MODEL OF FANCONI ANEMIA DANA FARBER CANCER INSTITUTE RESEARCH ACCOUNTING 450 BROOKLINE AVENUE MAIL STOP BP451 BOSTON MA 02215 042263040 501(c)(3) 39754 0 N/A N/A IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD DANA FARBER CANCER INSTITUTE MED ONCOLOGY GMO LW 258 BOSTON MA 02215 042263040 501(c)(3) 97500 0 N/A N/A BLOOD TESTS FOR THE EARLY DETECTION OF LUNG CANCER DISTRICT OF COLUMBIA GOV-DC TREASURY 899 NORTH CAPITOL NE 4TH FLOOR WASHINGTON DC 20002 536001131 DISTRICT OF COLUMBIA 629591 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR DUKE UNIVERSITY OFFICE OF SPONSORED PROGRAMS 2200 WEST MAIN STREET SUITE 300 DURHAM NC 277054677 560532129 501(c)(3) 2138648 0 N/A N/A HVTN LABORATORY PROGRAM DUKE UNIVERSITY OFFICE OF SPONSORED PROGRAMS 2200 WEST MAIN STREET SUITE 300 DURHAM NC 277054677 560532129 501(c)(3) 31274 0 N/A N/A MECHANISM-BASED CLASSIFICATION AND TARGETING OF CASTRATI EMORY UNIVERSITY GRANTS & CONTRACTS ACCOUNTING 1599 CLIFTON ROAD NE 4TH FLOOR MS 1599-001-1BH ATLANTA GA 303224250 580566256 501(c)(3) 597689 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL EMORY UNIVERSITY GRANTS & CONTRACTS ACCOUNTING 1599 CLIFTON ROAD NE 4TH FLOOR MS 1599-001-1BH ATLANTA GA 303224250 580566256 501(c)(3) 799367 0 N/A N/A HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF EMORY UNIVERSITY GRANTS & CONTRACTS ACCOUNTING 1599 CLIFTON ROAD NE 4TH FLOOR MS 1599-001-1BH ATLANTA GA 303224250 580566256 501(c)(3) 132381 0 N/A N/A CONTAINING BIOTERRORISM AND EMERGING INFECTIOUS DISEASES EXPONENT INC P O BOX 200283 DEPT 002 DALLAS TX 753200283 770218904 10500 0 N/A N/A THE FEASIBILITY OF EARLIER DETECTION OF OVARIAN CANCER U FENWAY COMMUNITY HEALTH FINANCE 1340 BOYLSTON ST 9TH FLOOR BOSTON MA 02215 042510564 501(c)(3) 866490 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL FENWAY COMMUNITY HEALTH FINANCE 1340 BOYLSTON ST 9TH FLOOR BOSTON MA 02215 042510564 501(c)(3) 11186 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL FRONTIER SCIENCE AND TECHNOLOGY P O BOX 983027 BOSTON MA 022983027 161056814 501(c)(3) 124565 0 N/A N/A HVTN LABORATORY PROGRAM FRONTIER SCIENCE AND TECHNOLOGY P O BOX 983027 BOSTON MA 022983027 161056814 501(c)(3) 48960 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HVTN FRONTIER SCIENCE AND TECHNOLOGY P O BOX 983027 BOSTON MA 022983027 161056814 501(c)(3) 92708 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR FRONTIER SCIENCE AND TECHNOLOGY P O BOX 983027 BOSTON MA 022983027 161056814 501(c)(3) 35874 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- MICRO GENERAL HOSPITAL CORPORATION DBA RESEARCH FINANCE P O BOX 414876 BOSTON MA 022414876 042697983 501(c)(3) 19780 0 N/A N/A MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F GENERAL HOSPITAL CORPORATION DBA RESEARCH FINANCE P O BOX 3829 BANK OF AMERICA NA BOSTON MA 022413829 042697983 501(c)(3) 393163 0 N/A N/A EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN GENERAL HOSPITAL CORPORATION DBA RESEARCH FINANCE P O BOX 3829 BANK OF AMERICA NA BOSTON MA 022413829 042697983 501(c)(3) 43074 0 N/A N/A MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C GROUP HEALTH COOPERATIVE P O BOX 34587 SEATTLE WA 981249990 910511770 501(c)(3) 12528 0 N/A N/A COLON CANCER PATHWAYS- HYPERPLASTICS POLYPS AND ADENOMA GROUP HEALTH COOPERATIVE P O BOX 34587 SEATTLE WA 981249990 910511770 501(c)(3) 6733 0 N/A N/A MODELING US PROSTATE CANCER TRENDS- PSA/ TREATMENT & RAC GROUP HEALTH COOPERATIVE ATTN CASH DESK P O BOX 34587 SEATTLE WA 981249990 910511770 501(c)(3) 28515 0 N/A N/A PREVENTION OF OVARIAN CANCER IN WOMEN PARTICIPATING IN M GROUP HEALTH COOPERATIVE P O BOX 34587 SEATTLE WA 981249990 910511770 501(c)(3) 143185 0 N/A N/A MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F GROUP HEALTH COOPERATIVE P O BOX 34587 SEATTLE WA 981249990 910511770 501(c)(3) 159961 0 N/A N/A ACCEPTANCE AND COMMITMENT THERAPY FOR SMOKING CESSATI H LEE MOFFITT CANCER CENTER MRC-RESADIM 122902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 501(c)(3) 34612 0 N/A N/A IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD H LEE MOFFITT CANCER CENTER MRC-RESADIM 122902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 501(c)(3) 55205 0 N/A N/A IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC HARBORVIEW MEDICAL CENTER 325 NINTH AVE BOX 359750 SEATTLE WA 98104 911631806 County Med Ctr 39448 0 N/A N/A LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE HEKTOEN INSTITUTE FOR MED RESEARCH LLC 2240 W OGDEN AVE CHICAGO IL 606129982 362244897 501(c)(3) 103957 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR HEMATOLOGICS INC P O BOX 24712 SEATTLE WA 98124 911685196 56100 0 N/A N/A BRIDGE FUNDING- MOLECULAR ASSESSMENT OF MINIMAL RISK DIS HENRY M JACKSON FOUNDATION FOR THE 1401 ROCKVILLE PIKE SUITE 600 ROCKVILLE MD 20852 521317896 501(c)(3) 210196 0 N/A N/A HVTN LABORATORY PROGRAM IMMUNE DESIGN CORP 1124 COLUMBIA ST SUITE 700 SEATTLE WA 98104 262007174 16668 0 N/A N/A WASHINGTON VACCINE ALLIANCE INDIANA UNIVERSITY FINANCIAL MANAGEMENT SUPPORT P O BOX 66057 INDIANAPOLIS IN 462666057 356001673 University 265622 0 N/A N/A MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F INFECTIOUS DISEASE CNSLTNTS MD PA DBA 1701 N MILLS AVE ORLANDO FL 32803 591634257 902898 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL INSTITUTE FOR SYSTEMS BIOLOGY 1441 NORTH 34TH STREET SEATTLE WA 981038904 912003593 501(c)(3) 750341 0 N/A N/A HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF JOHNS HOPKINS UNIVERSITY C/O BANK OF AMERICA 12529 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 520595110 501(c)(3) 110838 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL JOHNS HOPKINS UNIVERSITY C/O BANK OF AMERICA 12529 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 520595110 501(c)(3) 109846 0 N/A N/A BIOCONDUCTOR- AN OPEN COMPUTING RESOURCE FOR GENOMICS JOHNS HOPKINS UNIVERSITY C/O BANK OF AMERICA 12529 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 520595110 501(c)(3) 12861 0 N/A N/A GENETIC PROGRESSION OF PANCREATIC MUCINOUS CYSTIC NEOPLA KAISER FOUNDATION HOSPITALS KAISER FOUNDATION RESEARCH INSTITUTE 1800 HARRISON STREET 16TH FLOOR OAKLAND CA 946123433 941105628 501(c)(3) 143728 0 N/A N/A CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT KAISER FOUNDATION HOSPITALS KAISER FOUNDATION RESEARCH INSTITUTE 1800 HARRISON STREET 16TH FLOOR OAKLAND CA 946123433 941105628 501(c)(3) 156657 0 N/A N/A CORE ASSAYS MRLI - W1 W3 KAISER FOUNDATION HOSPITALS KAISER FOUNDATION RESEARCH INSTITUTE 1800 HARRISON STREET 16TH FLOOR OAKLAND CA 946123433 941105628 501(c)(3) 206642 0 N/A N/A MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F KAISER FOUNDATION HOSPITALS KAISER FOUNDATION RESEARCH INSTITUTE 1800 HARRISON STREET 16TH FLOOR OAKLAND CA 946123433 941105628 501(c)(3) 62181 0 N/A N/A BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI KAISER FOUNDATION HOSPITALS KAISER FOUNDATION RESEARCH INSTITUTE 1800 HARRISON STREET 16TH FLOOR OAKLAND CA 946123433 941105628 501(c)(3) 17459 0 N/A N/A UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES I LABKEY CORPORATION 2226 EASTLAKE AVE E Suite 101 SEATTLE WA 98102 208266728 501(c)(3) 60265 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HVTN LABKEY CORPORATION 2226 EASTLAKE AVE E Suite 101 SEATTLE WA 98102 208266728 501(c)(3) 10136 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- MICRO LABKEY CORPORATION 2226 EASTLAKE AVE E Suite 101 SEATTLE WA 98102 208266728 501(c)(3) 136078 0 N/A N/A CROSS-SPECIES HIV IMMUNOLOGY STATISTICS AND DATA CENTER LABKEY CORPORATION 2226 EASTLAKE AVE E Suite 101 SEATTLE WA 98102 208266728 501(c)(3) 21314 0 N/A N/A CABIG-ISRCE- IN SILICO RESEARCH CENTERS OF EXCELLENCE LOUISIANA STATE UNIVERSITY HEALTH INTERLIBRARY LOAN 433 BOLIVAR ST NEW ORLEANS LA 701122223 726087770 36136 0 N/A N/A IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND MAGEE WOMEN'S RESEARCH INSTITUTE OFFICE OF RESEARCH ADMINISTRATION 3339 WARD STREET PITTSBURGH PA 15213 251462312 501(c)(3) 7514 0 N/A N/A HVTN LABORATORY PROGRAM MASSACHUSETTS INSTITUTE OF TECHNOLOGY CASHIER'S OFFICE 77 MASSACHUSETTS AVENUE NE49-3077 CAMBRIDGE MA 02139 042103594 501(c)(3) 60636 0 N/A N/A HVTN LABORATORY PROGRAM MAYO CLINIC ROCHESTER DBA REMIT PROCESSING P O BOX 4008 ROCHESTER MN 559034008 416011702 501(c)(3) 121798 0 N/A N/A BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI MEDICAL COLLEGE OF WISCONSIN INC FINANCE & ADMINISTRATION 8701 WATERTOWN PLANK RD P O BOX 26509 MILWAUKEE WI 532260509 390806261 501(c)(3) 14960 0 N/A N/A IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD MEDICAL COLLEGE OF WISCONSIN INC FINANCE & ADMINISTRATION 8701 WATERTOWN PLANK RD P O BOX 26509 MILWAUKEE WI 532260509 390806261 501(c)(3) 13288 0 N/A N/A HEMATOPOPIETIC STEM CELL TRANSPLANTATION MEDICAL COLLEGE OF WISCONSIN INC DEPT OF PEDIATRICS M3018 8701 WATERTOWN PLANK RD MILWAUKEE WI 53226 390806261 501(c)(3) 24722 0 N/A N/A HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION MEDICAL UNIVERSITY OF SOUTH CAROLINA CASHIERS OFFICE 19 HAGOOD AVE SUITE 303 MSC 804 CHARLESTON SC 294258040 576000722 85103 0 N/A N/A RADIATION DOSE-DEPENDENT INTERVENTIONS MEDICAL UNIVERSITY OF SOUTH CAROLINA CASHIERS OFFICE 19 HAGOOD AVE SUITE 303 MSC 804 CHARLESTON SC 294258040 576000722 65221 0 N/A N/A HVTN LABORATORY PROGRAM MIRIAM HOSPITAL RHODE ISLAND HOSPITAL 593 EDDY STREET RES ADMIN-ALDRICH 3 PROVIDENCE RI 02903 050258905 501(c)(3) 28080 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL MOUNT SINAI SCHOOL OF MEDICINE ONE GUSTAVE L LEVY PLACE BOX 1410 NEW YORK NY 100296574 136171197 501(c)(3) 11631 0 N/A N/A A POOLED ANALYSIS OF RISK FACTORS OF SMALL INTESTINE CAN NATIONAL INSTITUTES OF HEALTH OFM DEFS GRANT ACCOUNTING BRANCH 31 CENTER DRIVE ROOM B1B11 MSC 2052 BETHESDA MD 208922052 520858115 NATIONAL INSTITUTES 125000 0 N/A N/A HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF NATIONAL JEWISH HEALTH 1400 JACKSON STREET ROOM M213 DENVER CO 80206 742044647 501(c)(3) 6803 0 N/A N/A A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L NEW YORK BLOOD CENTER INC 1200 PROSPECT AVENUE WESTBURY NY 11590 131949477 501(c)(3) 985166 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL NEW YORK UNIVERSITY SCHOOL OF MEDICINE ANTHONY MARSICANO-SPONSORED PROGRAMS P O BOX 415026 BOSTON MA 022415026 135562309 108598 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL NEW YORK UNIVERSITY SCHOOL OF MEDICINE ANTHONY MARSICANO-SPONSORED PROGRAMS P O BOX 415026 BOSTON MA 022415026 135562309 178833 0 N/A N/A HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF NORTHEASTERN UNIVERSITY 360 HUNTINGTON AVE BOSTON MA 02115 041679980 501(c)(3) 45828 0 N/A N/A NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGIN NORTHWEST COMMUNITIES EDUCATION CENTER KDNA RADIO STATION P O BOX 800 GRANGER WA 98932 910969818 501(c)(3) 26073 0 N/A N/A PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM NORTHWEST PORTLAND AREA INDIAN 2121 SW BROADWAY STE 300 PORTLAND OR 97201 930718154 501(c)(3) 6595 0 N/A N/A A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON NY CITY DEPT OF HLTH AND MENTAL HYGIENE ROSSANA VOLPE 42-09 28TH STREET WS 21-127 LONG ISLAND CITY NY 11101 136400434 501(c)(3) 757632 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR OHIO STATE UNIVERSITY RSRCH FOUNDATION ACCOUNTING DEPT 1960 KENNY RD 4TH FLOOR COLUMBUS OH 432101063 316401599 501(c)(3) 19676 0 N/A N/A EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE OHIO STATE UNIVERSITY RSRCH FOUNDATION ACCOUNTING DEPT 1960 KENNY RD 4TH FLOOR COLUMBUS OH 432101063 316401599 501(c)(3) 16661 0 N/A N/A GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES OREGON HEALTH & SCIENCE UNIVERSITY SPONSORED PROJECTS ADMINISTRATION 2525 SW FIRST AVENUE SUITE 220 PORTLAND OR 97201 931176109 University 1425170 0 N/A N/A HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF OREGON HEALTH & SCIENCE UNIVERSITY SPONSORED PROJECTS ADMINISTRATION 2525 SW FIRST AVENUE SUITE 220 PORTLAND OR 97201 931176109 University 1371527 0 N/A N/A IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK ROAD PORTLAND OR 97239 931176109 University 15400 0 N/A N/A THE PACIFIC NORTHWEST PROSTATE CANCER SPORE OREGON HEALTH & SCIENCE UNIVERSITY SPONSORED PROJECTS ADMINSTRATION 0690 SW BANCROFT ST MAILCODE L106SPA PORTLAND OR 97239 931176109 University 513586 0 N/A N/A IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND OREGON UNIVERSITY SYSTEM OFFICE OF RESEARCH SERVICES AND ADMINISTRATION 5219 UNIVERSITY OF OREGON EUGENE OR 974035219 936001786 University 497587 0 N/A N/A TILLING THE ZEBRAFISH GENOME- A REVERSE GENETICS APPROAC PRESIDENT AND FELLOWS OF HARVARD COLLEGE P O BOX 415649 BOSTON MA 022415649 042103580 501(c)(3) 129491 0 N/A N/A GENOME-WIDE PROFILING OF HISTONE VARIANTS IN DROSOPHILA PRESIDENT AND FELLOWS OF HARVARD COLLEGE P O BOX 415649 BOSTON MA 022415649 042103580 501(c)(3) 24073 0 N/A N/A STATISTICAL METHODS FOR PROSPECTIVE EVALUATION OF BIOMAR PRESIDENT AND FELLOWS OF HARVARD COLLEGE P O BOX 415649 BOSTON MA 022415649 042103580 501(c)(3) 8132 0 N/A N/A GENOME-WIDE PROFILINGOF HISTONE VARIANTS IN DROSOPHILA A PRESIDENT AND FELLOWS OF HARVARD COLLEGE P O BOX 415649 BOSTON MA 022415649 042103580 501(c)(3) 26182 0 N/A N/A EPIGENOMIC PROFILING OF HISTONE TURNOVER KINETICS IN MAM PROVIDENCE HEALTH & SERVICES-WASHINGTON 3200 PROVIDENCE DRIVE ANCHORAGE AK 99508 920016429 Hospital 41114 0 N/A N/A LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE PUBLIC HEALTH FOUNDATION ENTERPRISES INC 12801 CROSSROADS PARKWAY SOUTH Suite 200 CITY OF INDUSTRY CA 91746 952557063 501(c)(3) 1050110 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL PUBLIC HEALTH FOUNDATION ENTERPRISES INC 12801 CROSSROADS PARKWAY SOUTH Suite 200 CITY OF INDUSTRY CA 91746 952557063 501(c)(3) 45693 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL PUGET SOUND BLOOD CENTER AND PROGRAM 921 TERRY AVENUE SEATTLE WA 981041256 911019655 501(c)(3) 171210 0 N/A N/A THERAPIES FOR HEMATOPOIETIC SYNDROME, BONE MARROW STROMA PUGET SOUND BLOOD CENTER AND PROGRAM 921 TERRY AVENUE SEATTLE WA 981041256 911019655 501(c)(3) 44763 0 N/A N/A CORE CENTER OF EXCELLENCE IN HEMATOLOGY REGENTS OF THE UNIV OF CALIFORNIA ACCOUNTING OFFICE - EMF BOX 0897 SAN FRANCISCO CA 94143 946036493 University 76274 0 N/A N/A MECHANISM-BASED CLASSIFICATION AND TARGETING OF CASTRATI REGENTS OF THE UNIV OF CALIFORNIA ACCOUNTING OFFICE - EMF BOX 0897 SAN FRANCISCO CA 94143 946036493 University 7905 0 N/A N/A MODELING PROSTATE CANCER CONTROL- PREVENTION/ SCREENING REGENTS OF THE UNIVERSITY BIOLOGICAL SCIENCES III ACCOUNTING OFFICE SUITE 1400 IRVINE CA 926971050 952226406 University 65036 0 N/A N/A EARLY AND REINFECTION IN HIGH RISK WOMEN REGENTS OF THE UNIVERSITY OF CA AT LOS REMITTANCE CENTER 405 HILGARD AVENUE 1125 MURPHY HALL BOX 951432 LOS ANGELES CA 900959000 956006143 University 78658 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL REGENTS OF THE UNIVERSITY OF CA AT LOS REMITTANCE CENTER 405 HILGARD AVENUE 1125 MURPHY HALL BOX 951432 LOS ANGELES CA 900959000 956006143 University 37945 0 N/A N/A EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA REGENTS OF THE UNIVERSITY OF CA AT LOS REMITTANCE CENTER 405 HILGARD AVENUE 1125 MURPHY HALL BOX 951432 LOS ANGELES CA 900959000 956006143 University 148363 0 N/A N/A MARKERS OF B-CELL STIMULATION AS POTENTIAL PREDICTORS OF REGENTS OF THE UNIVERSITY OF CA AT LOS REMITTANCE CENTER 405 HILGARD AVENUE 1125 MURPHY HALL BOX 951432 LOS ANGELES CA 900959000 956006143 University 22227 0 N/A N/A GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES REGENTS OF THE UNIVERSITY OF CALIFORNIA CASHIER'S OFFICE P O BOX 989062 WEST SACRAMENTO CA 957989062 946036494 University 92237 0 N/A N/A A PROSPECTIVE STUDY OF COLORECTAL CANCER- ONE-CARBON ME REGENTS OF THE UNIVERSITY OF CALIFORNIA CASHIER'S OFFICE P O BOX 989062 WEST SACRAMENTO CA 957989062 946036494 University 38813 0 N/A N/A STATISTICAL METHODS FOR INTEGRATIVE ANALYSIS OF GENOMICS REGENTS OF THE UNIVERSITY OF CALIFORNIA CASHIER'S OFFICE P O BOX 989062 WEST SACRAMENTO CA 957989062 946036494 University 172411 0 N/A N/A BISPECIFIC ANTIBODY ENGINEERING FOR AML RIT REGENTS OF THE UNIVERSITY OF MICHIGAN BOX 223131 PITTSBURGH PA 152512131 386006309 University 201571 0 N/A N/A MODELING PROSTATE CANCER CONTROL- PREVENTION/ SCREENING REGENTS OF THE UNIVERSITY OF MINNESOTA P O BOX 1450 NW 5957 MINNEAPOLIS MN 554855957 416007513 University 123125 0 N/A N/A CORE ASSAYS MRLI - W1 W3 REGENTS OF THE UNIVERSITY OF MINNESOTA P O BOX 1450 NW 5957 MINNEAPOLIS MN 554855957 416007513 University 87590 0 N/A N/A MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F REGENTS OF THE UNIVERSITY OF MINNESOTA P O BOX 1450 NW 5957 MINNEAPOLIS MN 554855957 416007513 University 9418 0 N/A N/A IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC REGENTS OF THE UNIVERSITY OF MINNESOTA P O BOX 1450 NW 5957 MINNEAPOLIS MN 554855957 416007513 University 25169 0 N/A N/A INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF REGENTS OF THE UNIVERSITY OF MINNESOTA P O BOX 1450 NW 5957 MINNEAPOLIS MN 554855957 416007513 University 51499 0 N/A N/A METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA REGENTS OF UNIVERSITY OF COLORADO OFFICE OF GRANTS & CONTRACTS-F428 DEPARTMENT 238 DENVER CO 802910238 846000555 University 186819 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL REGENTS OF UNIVERSITY OF COLORADO OFFICE OF GRANTS & CONTRACTS-F428 DEPARTMENT 238 DENVER CO 802910238 846000555 University 45639 0 N/A N/A VITAMIN D AND PROSTATE CANCER- BIOMARKERS AND GENETIC VA RESEARCH FOUNDATION OF STATE UNIVERSITY CASH RECEIPT DEPARTMENT P O BOX 9 ALBANY NY 122010009 141368361 501(c)(3) 63436 0 N/A N/A POPULATION PHARMACOKINETICS / PHARMACODYNAMICS IN NONABL RUSH UNIVERSITY MEDICAL CENTER FUND ACCOUNTING 1700 WEST VAN BUREN ROOM 277 CHICAGO IL 60612 362174823 501(c)(3) 12945 0 N/A N/A PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM SAINT JUDE CHILDRENS RESEARCH HOSPITAL P O BOX 1000 DEPT 949 MEMPHIS TN 381480949 620646012 501(c)(3) 18899 0 N/A N/A LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O SAINT LOUIS UNIVERSITY 3700 WEST PINE MALL FUSZ MEMORIAL HALL SUITE 357 SAINT LOUIS MO 63108 430654872 501(c)(3) 12794 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL SEATTLE BIOMEDICAL RESEARCH INSTITUTE 307 WESTLAKE AVE N SUITE 500 SEATTLE WA 981095219 910961784 501(c)(3) 179138 0 N/A N/A IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND SEATTLE CHILDREN'S P O BOX 34935 DEPT 736 SEATTLE WA 981241936 910564748 501(c)(3) 7369 0 N/A N/A LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE SEATTLE CHILDREN'S P O BOX 34935 DEPT 736 SEATTLE WA 981241936 910564748 501(c)(3) 90319 0 N/A N/A STEM CELL TRANSPLANTATION- BASIC/CLINICAL RESEARCH SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 97885 0 N/A N/A FUNCTION OF HUMAN AND MOUSE BETA-GLOBIN LOCUS CONTROL RE SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 27690 0 N/A N/A PREGNANCY, MICROCHIMERISM, AND AUTOIMMUNE DISEASE SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 143530 0 N/A N/A CANCER CENTER SUPPORT GRANT (COMPREHENSIVE) SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 50890 0 N/A N/A ACTIVATION AND SILENCING OF GENE EXPRESSION DURING HEMAT SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 87919 0 N/A N/A TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMOR SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 33020 0 N/A N/A TOWARDS A MODEL OF FANCONI ANEMIA SEATTLE CHILDREN'S P O BOX 34935 DEPT 736 SEATTLE WA 981241936 910564748 501(c)(3) 21330 0 N/A N/A DIGITAL DNASEL MAPPING AND FOOTPRINTING OF THE MOUSE GEN SEATTLE CHILDREN'S P O BOX 34935 DEPT 736 SEATTLE WA 981241936 910564748 501(c)(3) 115368 0 N/A N/A METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 31899 0 N/A N/A CONSORTIUM BIOSPECIMEN PROGRAM SEATTLE CHILDREN'S P O BOX 24728 SEATTLE WA 981240728 910564748 501(c)(3) 21255 0 N/A N/A A COMPREHENSIVE CATALOGUE OF MOUSE DNASEI HYPERSENSITIVE SEATTLE INST FOR BIOMED & CLINICAL RES 1660 SOUTH COLUMBIAN WAY S-151F SEATTLE WA 98108 911452438 501(c)(3) 207761 0 N/A N/A THE PACIFIC NORTHWEST PROSTATE CANCER SPORE SEATTLE INST FOR BIOMED & CLINICAL RES 1660 SOUTH COLUMBIAN WAY S-151F SEATTLE WA 98108 911452438 501(c)(3) 36970 0 N/A N/A IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON NORMA SLOAN KETTERING INSTITUTE FOR MSKCC FINANCE P O BOX 26338 GENERAL POST OFFICE NEW YORK NY 10087 131624182 501(c)(3) 26131 0 N/A N/A GENOME-WIDE ASSOCIATION STUDY OF ENDOMETRIAL CANCER SLOAN KETTERING INSTITUTE FOR MSKCC FINANCE P O BOX 26338 GENERAL POST OFFICE NEW YORK NY 10087 131624182 501(c)(3) 63504 0 N/A N/A HEMATOPOPIETIC STEM CELL TRANSPLANTATION SLOAN KETTERING INSTITUTE FOR MSKCC FINANCE P O BOX 26338 GENERAL POST OFFICE NEW YORK NY 10087 131624182 501(c)(3) 229160 0 N/A N/A HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION SUNNYSIDE COMMUNITY HOSPITAL INC P O BOX 719 SUNNYSIDE WA 98944 911286274 501(c)(3) 56658 0 N/A N/A PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM SWEDISH HEALTH SERVICES SWEDISH HEALTH SERVICES GRANTS P O BOX 94085 SEATTLE WA 981249485 910433740 501(c)(3) 10765 0 N/A N/A PREVENTION OF OVARIAN CANCER IN WOMEN PARTICIPATING IN M TORREY PINES INST FOR MOLECULAR STUDIES 11350 SW VILLAGE PARKWAY PORT ST LUCIE FL 34987 330319501 501(c)(3) 165937 0 N/A N/A IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CAN TRANSLATIONAL GENOMICS RES INSTITUTE 445 N 5TH ST SUITE 600 PHOENIX AZ 85004 753065445 501(c)(3) 26253 0 N/A N/A GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C TRANSLATIONAL GENOMICS RES INSTITUTE 445 N 5TH ST SUITE 600 PHOENIX AZ 85004 753065445 501(c)(3) 55174 0 N/A N/A A PROSPECTIVE STUDY OF COLORECTAL CANCER- ONE-CARBON ME TRANSLATIONAL GENOMICS RES INSTITUTE 445 N 5TH ST SUITE 600 PHOENIX AZ 85004 753065445 501(c)(3) 90306 0 N/A N/A EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE TRANSLATIONAL GENOMICS RES INSTITUTE 445 N 5TH ST SUITE 600 PHOENIX AZ 85004 753065445 501(c)(3) 716287 0 N/A N/A INFLAMMATION AND THROMBOSIS GENE PATHWAYS AND CARDIOVASC TRANSLATIONAL GENOMICS RES INSTITUTE 445 N 5TH ST SUITE 600 PHOENIX AZ 85004 753065445 501(c)(3) 360551 0 N/A N/A COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR TRANSLATIONAL GENOMICS RES INSTITUTE 445 N 5TH ST SUITE 600 PHOENIX AZ 85004 753065445 501(c)(3) 162204 0 N/A N/A EPIDEMIOLOGY OF PUTATIVE GENUINE GENETIC VARIANT- THE WO TRUSTEES OF COLUMBIA UNIVERSITY IN CU RESEARCH ADMINISTRATION P O BOX 29789 NEW YORK NY 100879789 135598093 501(c)(3) 1592938 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL TRUSTEES OF THE UNIVERSITY OF P O BOX 785541 PHILADELPHIA PA 191785541 231352685 501(c)(3) 18023 0 N/A N/A TREC COORDINATION CENTER TRUSTEES OF THE UNIVERSITY OF P O BOX 785541 PHILADELPHIA PA 191785541 231352685 501(c)(3) 1462383 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL TRUSTEES OF THE UNIVERSITY OF P O BOX 785541 PHILADELPHIA PA 191785541 231352685 501(c)(3) 53057 0 N/A N/A GENOME-WIDE ASSOCIATION STUDY OF ENDOMETRIAL CANCER UNIVERSITY OF ALABAMA BIRMINGHAM GRANTS AND CONTRACTS ACCOUNTING 1530 THIRD AVENUE SOUTH AB 990 BIRMINGHAM AL 352940109 636005396 University 583202 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL UNIVERSITY OF GEORGIA RESEARCH UGA CONTRACTS & GRANTS C/O PAM RAY 475 N LUMPKIN STREET Athens GA 30602 581353149 501(c)(3) 5168 0 N/A N/A FUNCTIONAL METHODS FOR RADIATION EXPOSURE AND BIOMARKER UNIVERSITY OF HAWAII OFFICE OF RESEARCH SERVICES 2530 DOLE STREET SAKAMAKI D200 HONOLULU HI 96822 996000354 University 117148 0 N/A N/A COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR UNIVERSITY OF IDAHO OFFICE OF SPONSORED PROGRAMS P O BOX 443020 MOSCOW ID 838443020 826000945 University 7090 0 N/A N/A WASHINGTON VACCINE ALLIANCE UNIVERSITY OF IDAHO OFFICE OF SPONSORED PROGRAMS P O BOX 443020 MOSCOW ID 838443020 826000945 University 113425 0 N/A N/A WASHINGTON VACCINE ALLIANCE UNIVERSITY OF NEW MEXICO HSC CONTRACT AND GRANT ACCOUNTING 1 UNIVERSITY OF NEW MEXICO MSC09 5225 ALBUQUERQUE NM 871310001 856000642 University 51671 0 N/A N/A REDUCING OBESITY AT THE WORKPLACE- A RANDOMIZED TRIAL UNIVERSITY OF NEW MEXICO HSC CONTRACT AND GRANT ACCOUNTING 1 UNIVERSITY OF NEW MEXICO MSC09 5225 ALBUQUERQUE NM 871310001 856000642 University 39700 0 N/A N/A TREC- MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION UNIVERSITY OF NEW MEXICO HSC CONTRACT AND GRANT ACCOUNTING 1 UNIVERSITY OF NEW MEXICO MSC09 5225 ALBUQUERQUE NM 871310001 856000642 University 79375 0 N/A N/A TREC COORDINATION CENTER UNIVERSITY OF NEW MEXICO HSC CONTRACT AND GRANT ACCOUNTING 1 UNIVERSITY OF NEW MEXICO MSC09 5225 ALBUQUERQUE NM 871310001 856000642 University 283549 0 N/A N/A UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES I UNIVERSITY OF NO CAROLINA AT CHARLOTTE FINANCIAL SERVICES/SPONSORED PROGRAMS 9201 UNIVERSITY CITY BOULEVARD CHARLOTTE NC 282230001 560791228 University 98266 0 N/A N/A STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS UNIVERSITY OF NORTH CAROLINA OFFICE OF SPONSORED RESEARCH P O BOX 402420 ATLANTA GA 303842420 566001393 University 244549 0 N/A N/A CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT UNIVERSITY OF NORTH CAROLINA OFFICE OF SPONSORED RESEARCH P O BOX 402420 ATLANTA GA 303842420 566001393 University 23315 0 N/A N/A BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI UNIVERSITY OF NORTH CAROLINA OFFICE OF SPONSORED RESEARCH P O BOX 402420 ATLANTA GA 303842420 566001393 University 26613 0 N/A N/A MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C UNIVERSITY OF NORTH CAROLINA OFFICE OF SPONSORED RESEARCH P O BOX 402420 ATLANTA GA 303842420 566001393 University 51675 0 N/A N/A STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS UNIVERSITY OF PITTSBURGH OFFICE OF RES/COST ACCTG 3109 CATHEDRAL OF LEARNING PITTSBURGH PA 15260 250965591 501(c)(3) 15359 0 N/A N/A HVTN LABORATORY PROGRAM UNIVERSITY OF PITTSBURGH P O BOX 371220 PITTSBURGH PA 152517220 250965591 501(c)(3) 17928 0 N/A N/A EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE UNIVERSITY OF PITTSBURGH OFFICE OF RES/COST ACCTG 3109 CATHEDRAL OF LEARNING PITTSBURGH PA 15260 250965591 501(c)(3) 24793 0 N/A N/A COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR UNIVERSITY OF PITTSBURGH OFFICE OF RES/COST ACCTG 3109 CATHEDRAL OF LEARNING PITTSBURGH PA 15260 250965591 501(c)(3) 16424 0 N/A N/A GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES UNIVERSITY OF PITTSBURGH 642 B SCAIFE HALL 3550 TERRACE STREET PITTSBURGH PA 15261 250965591 501(c)(3) 15150 0 N/A N/A A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L UNIVERSITY OF ROCHESTER OFFICE OF RESEARCH ACCT & COST STANDARDS 910 GENESEE STREET SUITE 200 ROCHESTER NY 146113847 160743209 1160817 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL UNIVERSITY OF ROCHESTER OFFICE OF RESEARCH ACCT & COST STANDARDS 910 GENESEE STREET SUITE 200 ROCHESTER NY 146113847 160743209 181772 0 N/A N/A THE PATHOGENESIS OF FMD- FACIOSCAPULOHUMERAL MUSCULAR UNIVERSITY OF SOUTHERN CALIFORNIA FILE NO 52095 SPONSORED PROJECTS ACCOUNTING LOS ANGELES CA 900742095 951642394 17198 0 N/A N/A BIOLOGY AND PROGNOSTIC IMPLICATIONS OF FLT3 MUTATIONS IN UNIVERSITY OF SOUTHERN CALIFORNIA FILE NO 52095 SPONSORED PROJECTS ACCOUNTING LOS ANGELES CA 900742095 951642394 20599 0 N/A N/A BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI UNIVERSITY OF SOUTHERN CALIFORNIA FILE NO 52095 SPONSORED PROJECTS ACCOUNTING LOS ANGELES CA 900742095 951642394 207595 0 N/A N/A IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD UNIVERSITY OF SOUTHERN CALIFORNIA FILE NO 52095 SPONSORED PROJECTS ACCOUNTING LOS ANGELES CA 900742095 951642394 21068 0 N/A N/A IRF8 AS A BIOMARKER OF AGING, MALIGNANT TRANSFORMATION, UNIVERSITY OF SOUTHERN CALIFORNIA FILE NO 52095 SPONSORED PROJECTS ACCOUNTING LOS ANGELES CA 900742095 951642394 5445 0 N/A N/A THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM- PHASE UNIVERSITY OF SOUTHERN CALIFORNIA FILE NO 52095 SPONSORED PROJECTS ACCOUNTING LOS ANGELES CA 900742095 951642394 70556 0 N/A N/A BIOMARKER FOR RISK IDENTIFICATION AND RISK-BASED THERAPY UNIVERSITY OF TEXAS HEALTH SCIENCES FINANCIAL ADMINSTRATIVE SUPPORT P O BOX 203382 HOUSTON TX 772163382 741761309 University 34049 0 N/A N/A PROSTAGLANDIN SYNTHESIS, GENETICS AND COLORECTAL CANCER UNIVERSITY OF TEXAS HEALTH SCIENCES FINANCIAL ADMINSTRATIVE SUPPORT P O BOX 203382 HOUSTON TX 772163382 741761309 University 9671 0 N/A N/A PREGNANCY, MICROCHIMERISM, AND AUTOIMMUNE DISEASE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL OFFICE OF POST AWARD ADMINISTRATION P O BOX 841765 DALLAS TX 752841765 756002868 University 663573 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL UNIVERSITY OF TEXAS MD ANDERSON GRANTS & CONTRACTS ACCOUNTING P O BOX 4390 HOUSTON TX 772104390 746001118 293764 0 N/A N/A IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD UNIVERSITY OF UTAH GRANTS & CONTRACTS ACCOUNTING 201 S PRESIDENTS CIRCLE RM 406 SALT LAKE CITY UT 841129020 876000525 University 93134 0 N/A N/A PROSTAGLANDIN SYNTHESIS, GENETICS AND COLORECTAL CANCER UNIVERSITY OF UTAH GRANTS & CONTRACTS ACCOUNTING 201 S PRESIDENTS CIRCLE RM 406 SALT LAKE CITY UT 841129020 876000525 University 52618 0 N/A N/A GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C UNIVERSITY OF UTAH GRANTS & CONTRACTS ACCOUNTING 201 S PRESIDENTS CIRCLE RM 406 SALT LAKE CITY UT 841129020 876000525 University 79474 0 N/A N/A THE TIME DISTRIBUTION METHOD FOR MEASURING CLINICALLY VA UNIVERSITY OF VERMONT AND P O BOX 1389 WILLISTON VT 054951389 030179440 University 12820 0 N/A N/A A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 5224 0 N/A N/A VANGUARD CLINICAL CENTER FOR CLINICAL TRIAL & OBSERVATIO UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 23322 0 N/A N/A CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 33210 0 N/A N/A ENHANCING LONG-TERM 5-A-DAY BEHAVIOR CHANGE IN WORKSITES UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 170869 0 N/A N/A REDUCING OBESITY AT THE WORKPLACE- A RANDOMIZED TRIAL UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 27032 0 N/A N/A HEPATITIS B ESL EDUCATION FOR CHINESE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 279158 0 N/A N/A THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 10170 0 N/A N/A MODELING US PROSTATE CANCER TRENDS- PSA/ TREATMENT & RAC UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 175563 0 N/A N/A RADIATION DOSE-DEPENDENT INTERVENTIONS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 20101 0 N/A N/A CORE CENTER OF EXCELLENCE IN HEMATOLOGY UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 260501 0 N/A N/A TREC- MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 46849 0 N/A N/A ASTATINE-211 CONDITIONING FOR NONMYELOABLATIVE HEMOPOIET UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 10690 0 N/A N/A THE ROLE OF UNCULTIVATED BACTERIA IN BACTERIAL VAGINOSIS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 5074474 0 N/A N/A HVTN LABORATORY PROGRAM UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 53229 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HVTN UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 271858 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- HIV PR UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 167751 0 N/A N/A LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS- MICRO UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 2843022 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 39353 0 N/A N/A GENE THERAPY FOR FANCONI ANEMIA UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 93459 0 N/A N/A CORD BLOOD EXPANSION AND TRANSPLANTATION IN A NON-HUMAN UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 52541 0 N/A N/A HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 105188 0 N/A N/A IN UTERO TRANSPLANTATION IN PRIMATES UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 9903 0 N/A N/A HEMATOPOIETIC CHEMOPROTECTION IN GLIOBLASTOMA PATIENTS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 58052 0 N/A N/A CORE ASSAYS MRLI - W1 W3 UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 354034 0 N/A N/A SEATTLE VACCINE TRIALS UNIT UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 124618 0 N/A N/A LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 5345 0 N/A N/A TGF-beta SIGNALING AND COLON CANCER UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 296333 0 N/A N/A CYTOTOXIC T CELL RESPONSE TO HSV IN HIV INFECTED PEOPLE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 37946 0 N/A N/A THE FANCONI ANEMIA-BRCA PATHWAY AND CHEMOSENSITIVITY OF UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 438532 0 N/A N/A IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 6598 0 N/A N/A HPV- BIOLOGY, CLINICAL SIGNIFICANCE AND EPIDEMIOLOGY UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 14346 0 N/A N/A NIGHT SHIFT WORK AND HORMONE LEVELS IN MEN UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 45817 0 N/A N/A IMPROVING GASTROINTESTINAL RECOVERY AFTER RADIATION UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 14824 0 N/A N/A A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 118163 0 N/A N/A CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICA UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 269084 0 N/A N/A IMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 747154 0 N/A N/A THE PACIFIC NORTHWEST PROSTATE CANCER SPORE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 147366 0 N/A N/A PRETARGETED RADIOIMMUNOTHERAPY OF CD20+ LYMPHOMAS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 102860 0 N/A N/A THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSI UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 45106 0 N/A N/A A PROSPECTIVE STUDY OF COLORECTAL CANCER- ONE-CARBON ME UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 17853 0 N/A N/A EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 1837844 0 N/A N/A CLINICAL EPIDEMIOLOGY AND PATHOGENESIS OF ASYMPTOMATIC H UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 201405 0 N/A N/A FRED HUTCHINSON/UNIVERSITY OF WASHINGTON CANCER CONSORTI UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 28092 0 N/A N/A OUTCOMES BASED GUIDELINE DEVELOPMENT FOR PROSTATE CANCER UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 7716 0 N/A N/A MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 1954635 0 N/A N/A CANCER CENTER SUPPORT GRANT (COMPREHENSIVE) UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 230773 0 N/A N/A MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 72753 0 N/A N/A IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON NORMA UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 69340 0 N/A N/A CD8+ CELL IMMUNITY TO CYTOMEGALOVIRUS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 126623 0 N/A N/A MITIGATION OF RADIATION-INDUCED LUNG INJURY IN THE DOG M UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 19193 0 N/A N/A WASHINGTON VACCINE ALLIANCE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 158660 0 N/A N/A CD45 PRETARGETED RADIOIMMUNOTHERAPY FOR AML UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 1309088 0 N/A N/A MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 26099 0 N/A N/A NORTH AMERICAN SHWACHMAN-DIAMOND SYNDROME REGISTRY UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 226679 0 N/A N/A DEVELOPMENT OF NOVEL AIDS GENE THERAPY STRATEGIES IN THE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 8145 0 N/A N/A SCHWACHMAN-DIAMOND SYNDROME INTERNATIONAL REGISTRY AND R UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 851622 0 N/A N/A PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 155909 0 N/A N/A INNATE RESISTANCE TO MUCOSAL HSV INFECTION IN HUMANS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 47623 0 N/A N/A ORAL CANCER- MOLECULAR PROFILES & CLINICAL OUTCOMES UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 209749 0 N/A N/A CHEMOPROTECTION AGAINST AMINOGLYCOSIDE-INDUCED OTOTOXICI UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 99879 0 N/A N/A COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 293477 0 N/A N/A BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 57389 0 N/A N/A PRECLINICAL GENE THERAPY STUDIES IN CANINE MUSCULAR DYST UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 29947 0 N/A N/A INFLAMMATORY DENDRITIC CELLS IN ADIPOSE TISSUE INFLAMMAT UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 234061 0 N/A N/A SEATTLE CANCER CONSORTIUM BREAST SPORE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 142177 0 N/A N/A DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 72981 0 N/A N/A HIV TESTING IN GENITAL TRACT SECRETIONS - MERCK SITES' S UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 29723 0 N/A N/A HPV CAPSID ANTIBODIES UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 439542 0 N/A N/A INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 48877 0 N/A N/A ANALYSIS OF A NOVEL SUBSET OF HUMAN CD8+ MEMORY CELLS WI UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 254771 0 N/A N/A CONTROLLING HEMATOPOIETIC LINEAGE COMMITMENT FROM ESC TO UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 564632 0 N/A N/A EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 307517 0 N/A N/A THE PATHOGENESIS OF FMD- FACIOSCAPULOHUMERAL MUSCULAR UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 167057 0 N/A N/A UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES I UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 361601 0 N/A N/A CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 88292 0 N/A N/A ANALYZING HETEROGENEITY OF ONCOGENIC PATHWAY ACTIVATION UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 14408 0 N/A N/A MERCK AURORA KINASE A INHIBITOR STUDY (MK-5108) UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 60137 0 N/A N/A A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 42719 0 N/A N/A LATE EFFECTS OF TREATMENT IN WILMS TUMOR SURVIVORS AND O UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 100652 0 N/A N/A GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 202864 0 N/A N/A CONSORTIUM BIOSPECIMEN PROGRAM UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 196702 0 N/A N/A EARLY AND REINFECTION IN HIGH RISK WOMEN UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 59201 0 N/A N/A NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGIN UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 144659 0 N/A N/A VIRAL PANELS DATABASE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 10744 0 N/A N/A IDENTIFY AND VALIDATE NOVEL EPIGENETIC MOLECULAR MARKERS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 24900 0 N/A N/A LYMPH NODE ALTERATIONS IN CANCER UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 149868 0 N/A N/A STRATEGIES TO IMPROVE THE ADOPTIVE TRANSFER OF T CELLS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 17110 0 N/A N/A NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS) UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 68121 0 N/A N/A MODELING PROSTATE CANCER CONTROL- PREVENTION/ SCREENING UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 13412 0 N/A N/A ADIPOSE TISSUE INFLAMMATION AND ESTROGEN SYNTHESIS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 89979 0 N/A N/A STATISTICAL METHODS IN HIV/AIDS RESEARCH UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 58352 0 N/A N/A NOVEL COMPUTATIONAL TOOLS FOR STUDYING THE HUMAN MICROBI UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 156777 0 N/A N/A CANCER IMMUNOTHERAPY TRIALS NETWORK CENTRAL OPERATIONS UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 40388 0 N/A N/A CORE CENTER OF EXCELLENCE IN HEMATOLOGY UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 68194 0 N/A N/A CORE CENTER OF EXCELLENCE IN HEMATOLOGY UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 149283 0 N/A N/A WASHINGTON VACCINE ALLIANCE UNIVERSITY OF WASHINGTON 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 University 810196 0 N/A N/A FRED HUTCHINSON/UNIVERSITY OF WASHINGTON CANCER CONSORTI UNIVERSITY OF WISCONSIN OFFICE FOR RESEARCH and SPONSORED PROGRAMS DRAWER 538 MILWAUKEE WI 532780538 396006492 University 7491 0 N/A N/A CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT UNIVERSITY OF WISCONSIN OFFICE FOR RESEARCH and SPONSORED PROGRAMS DRAWER 538 MILWAUKEE WI 532780538 396006492 University 68304 0 N/A N/A NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS) VACCINE & GENE THERAPY INSTITUTE FLORIDA 11350 SW VILLAGE PARKWAY 3RD FLOOR PORT ST LUCIE FL 34987 364631835 501(c)(3) 326756 0 N/A N/A HVTN LABORATORY PROGRAM VANDERBILT UNIVERSITY DEPT OF FINANCE DEPT AT 40303 ATLANTA GA 311920303 620476822 501(c)(3) 986374 0 N/A N/A LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL VANDERBILT UNIVERSITY DEPT OF FINANCE DEPT AT 40303 ATLANTA GA 311920303 620476822 501(c)(3) 25261 0 N/A N/A IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD VANDERBILT UNIVERSITY 2301 VANDERBILT PLACE PMB 401591 NASHVILLE TN 372401591 620476822 501(c)(3) 385191 0 N/A N/A TILLING THE ZEBRAFISH GENOME- A REVERSE GENETICS APPROAC WAKE FOREST UNIVERSITY HEALTH SCIENCES CONTROLLERS OFFICE MEDICAL CENTER BOULEVARD WINSTON SALEM NC 27157 223849199 501(c)(3) 290404 0 N/A N/A CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT WASHINGTON STATE UNIVERSITY CASHIERS OFFICE P O BOX 641039 PULLMAN WA 991641039 916001108 University 103346 0 N/A N/A ENGINEERING ENZYMES FOR ANTI-TUMOR SUICIDE GENE THERAPY WASHINGTON STATE UNIVERSITY CASHIER'S OFFICE-SPS P O BOX 641027 240 FRENCH ADMINSTRATION BLDG PULLMAN WA 991641027 916001108 University 205475 0 N/A N/A WASHINGTON VACCINE ALLIANCE WASHINGTON UNIVERSITY DBA SPONSORED PROJECTS ACCOUNTING 700 ROSEDALE AVENUE CAMPUS BOX 1034 ST LOUIS MO 631121408 430653611 501(c)(3) 83220 0 N/A N/A RADIATION DOSE-DEPENDENT INTERVENTIONS WASHINGTON UNIVERSITY DBA ATTN WESTERVELT/TMP4172/944214 660 SOUTH EUCLID AVE CB8009 ST LOUIS MO 631108009 430653611 501(c)(3) 5400 0 N/A N/A IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD WEILL MEDICAL COLLEGE OF CORNELL UNIV RESEARCH ACCOUNTING DEPARTMENT 100 BROADWAY 8TH FLOOR NEW YORK NY 10005 131623978 10039 0 N/A N/A HVTN LABORATORY PROGRAM WISTAR INSTITUTE OF ANATOMY AND BIOLOGY 3601 SPRUCE STREET PHILADELPHIA PA 19104 236434390 501(c)(3) 83241 0 N/A N/A BARRETT'S ESOPHAGUS- PREDICTORS OF PROGRESSION YALE UNIVERSITY GRANTS & CONTRACT FINANCIAL ADMIN P O BOX 1873 NEW HAVEN CT 065081873 060646973 501(c)(3) 15977 0 N/A N/A TREC COORDINATION CENTER YALE UNIVERSITY GRANTS & CONTRACT FINANCIAL ADMIN P O BOX 1873 NEW HAVEN CT 065081873 060646973 501(c)(3) 73114 0 N/A N/A ADULT LEUKEMIA RESEARCH CENTER YALE UNIVERSITY GRANTS & CONTRACT FINANCIAL ADMIN P O BOX 1873 NEW HAVEN CT 065081873 060646973 501(c)(3) 8460 0 N/A N/A BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI YESHIVA UNIVERSITY ALBERT EINSTEIN COLLEGE OF MEDICINE 1300 MORRIS PARK AVE BELFER BLDG RM 1108 BRONX NY 10461 131624225 501(c)(3) 8709 0 N/A N/A INNATE RESISTANCE TO MUCOSAL HSV INFECTION IN HUMANS 143 184 SchI_P01_S00_L02 Schedule I, Part I, Line 2 Schedule I, Part I, Line 2 - Procedures for Monitoring the Use of Grant Funds: Once the notice of award has been received and the Center project ID activated, the subaward can be set up. The structure of the subaward will depend on how the Prime is set up. Generally at the Center, a new purchase order (PO) is requisitioned for each subaward for each year of a project. This allows the Research Coordinator (RC) to closely monitor subaward invoices and encumbrances. For our Subrecipients, it means a separate budget ID and final invoice each year. Carryover between years is not automatic. There are 5 primary stems. 1) Step one is within Office of Sponsored Research (OSR). The Grant Specialist notifies the Contract Specialist that a grant which includes a subaward has been funded, and provides to the Contract Specialist a copy of the award, the signed subaward application (if available) and any special instructions. A signed subaward application is important because it shows that the Subrecipient organization has reviewed and approved the budget and scope of work. 2) The RC sends the Contract Specialist a Subcontract Acquisition Form (SAF). This form provides authorization for the Contract Specialist to issue the subaward, and includes a scope of work, budget, and pertinent subrecipient information. It is necessary to provide the scope of work and budget on the SAF as these items may have changed from what was originally submitted in the subaward application. 3) The Contract Specialist requisitions the subaward PO, which the RC must approve. An e-mail is sent to the RC notifying them that the requisition is pending and requires approval. Because OSR does not have funds commitment authority the RC is required to approve all requisitions. 4) OSR collects information required to correctly set up the subaward. These items include Institutional Review Office (IRO) and Institutional Animal Care and Use Committee (IACUC) approval dates, confirmation of subaward Facilities and Administrative (F&A) rates and A-133 Audit reports, review of Prime special terms and conditions to determine flow-down, confirmation that the Subrecipient is not debarred, and other similar regulatory and administrative requirements. While much of this information is collected by OSR, the RC may, in addition to completing the SAF, be asked to assist in the collection of some of the documentation. 5) OSR writes the subaward agreement, and mails it to the Subrecipient for signature. Some agreements can be signed by OSR before mailing, while others will be sent unsigned. This is determined by the Contract Specialist based on the term of award and status of administrative and regulatory requirements. A copy of the initial subaward is sent to the RC. Once the subaward has been fully signed, a copy is sent to the RC for their files. No invoices should be approved by the RC until they have received a fully executed agreement. X X X 1 1 X X X X 0 0 0 0 0 0 0 0 0 Leland H Hartwell 468409 0 124481 0 0 0 0 0 41293 0 634183 0 0 0 Frederick R Appelbaum 519933 0 68421 0 0 0 0 0 43686 0 632040 0 0 0 Janell E Baldwin 182337 0 20000 0 0 0 0 0 32522 0 234859 0 0 0 Anthony Bozzuti 243506 0 12250 0 0 0 0 0 16074 0 271830 0 0 0 Jonathan Cooper 262763 0 0 0 0 0 0 0 38439 0 301202 0 0 0 Linda L Gainer 216720 0 30000 0 0 0 0 0 43292 0 290012 0 0 0 Mark T Groudine 319280 0 148900 0 0 0 16500 0 44556 0 529236 0 0 0 Randall C Main 328324 0 40000 0 0 0 0 0 44556 0 412880 0 0 0 Margaret Juliana McElrath 232458 0 0 0 0 0 14400 0 44791 0 291649 0 0 0 Ulrich W Mueller 222869 0 30000 0 0 0 0 0 47322 0 300191 0 0 0 Howard Albert Nachtrieb 212965 0 30000 0 0 0 0 0 47250 0 290215 0 0 0 Ross L Prentice 399255 0 0 0 0 0 0 0 44538 0 443793 0 0 0 Scott N Rusch 181776 0 20000 0 0 0 0 0 38218 0 239994 0 0 0 Douglas J Shaeffer 289538 0 30000 0 0 0 0 0 44807 0 364345 0 0 0 Myra H Tanita 398212 0 75000 0 0 0 6000 0 39780 0 518992 0 0 0 Barbara Trask 284882 0 0 0 0 0 16500 0 40278 0 341660 0 0 0 Steven G Self 281222 0 0 0 0 0 16500 0 51142 0 348864 0 0 0 F Marc Stewart 151503 0 45868 0 0 0 0 0 37179 0 234550 0 0 0 Rainier F Storb 247218 0 0 0 0 0 16500 0 40936 0 304654 0 0 0 James M Roberts 148155 0 0 0 0 0 0 0 35145 0 183300 0 0 0 Irwin D Bernstein 295080 0 0 0 0 0 16500 0 42665 0 354245 0 0 0 Martin A Cheever 288162 0 0 0 0 0 16500 0 40195 0 344857 0 0 0 Samir M Hanash 328794 0 0 0 0 0 0 0 43254 0 372048 0 0 0 Charles N Petty 262694 0 0 0 0 0 0 0 36995 0 299689 0 0 0 Henry F Warden 228116 0 33696 0 0 0 0 0 39064 0 300876 0 0 0 SchJ_P01_S00_L01a Schedule J, Part I, Line 1a First-class air travel is allowed consistent with federal reimbursement regulations and generally only when coach fare is not available. Airfare and normal travel expenses are paid for the President & Director's spouse for trips involving fundraising for the Center. Social club dues are paid for the Center's President & Director. Washington Health Care Facilities Authority 911108929 2007-11-15 5200000 See Part V. 0 0 0 Washington Health Care Facilities Authority 911108929 93978E6G2 2009-11-24 15381009 Refund bonds issued 11/1/2002 0 0 0 Washington Health Care Facilities Authority 911108929 93978E6G2 2009-11-24 8842608 Refund bonds issued 11/1/2002 0 0 0 Washington Health Care Facilities Authority 911108929 93978E6G2 2009-11-24 32093411 Refund bonds issued 11/1/2002 0 0 0 425274 0 5200000 0 0 0 35948 0 32182 5131870 0 0 2007 0 0 1 1 454841 0 15381009 1466385 0 0 169304 0 69174 0 0 0 2009 1 0 1 1 261490 0 8842608 843031 0 0 97333 0 39769 0 0 0 2009 1 0 1 1 949053 0 32093411 3059701 0 0 353262 0 144336 0 0 0 2009 1 0 1 1 0 0 0 0 1 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SchK_P01_S00_L00 Schedule K, Part I For the issue amount of $5,200,000 dated 11/15/2007, the description of purpose is to reimburse the Center for costs of acquiring real property and improvements and pay issuance costs. SchK_P01_S00_L00c Schedule K, Part I, Column c No CUSIP available for $5,200,000 (DTD 11/15/2007) and $30,000,000 (DTD 11/04/2010). SchK_P01_S00_L00f Schedule K, Part I, Column f For the CUSIP # 93978HBV6, bond issue amount of $84,147,349 dated 6/30/2011, the description of purpose is to repay a taxable bridge loan incurred by the Center to acquire land and the 1100 Eastlake Building in Seattle, Washington. To construct, remodel, renovate and equip health care facilities located at the 1100 Eastlake Building and at the Center's existing South Lake Union Campus in Seattle. To construct a connection between the 1100 Eastlake Building and the South Lake Union Campus. Washington Health Care Facilities Authority 911108929 93978E6G2 2009-11-24 18735275 Refund bonds issued 11/1/2002 0 0 0 Washington Health Care Facilities Authority 911108929 93978E6G2 2009-11-24 39972686 Refund bonds issued 11/1/2002 0 0 0 Washington Health Care Facilities Authority 911108929 2010-11-04 30000000 Acquisition of a six-story office building 0 0 0 Washington Health Care Facilities Authority 911108929 93978HCL7 2011-06-30 49522564 Refund bonds issued 11/15/2001 0 0 0 554031 0 18735275 1786172 0 0 206225 0 84260 0 0 0 2009 1 0 1 1 220585 0 39972686 3829025 0 0 627017 0 0 0 0 0 2009 1 0 1 1 0 0 30000000 0 0 0 367238 0 0 29216470 0 416292 2010 0 0 0 1 0 0 49522564 0 0 0 533360 0 0 0 0 142632 2011 1 0 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 1 0 1 0.005 0 0.005 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 Washington Health Care Facilities Authority 911108929 93978HCL7 2011-06-30 33478278 Refund bonds issued 11/24/2009 0 0 0 Washington Health Care Facilities Authority 911108929 93978HBT1 2011-06-30 34532776 Refund bonds issued 11/15/2001 0 0 0 Washington Health Care Facilities Authority 911108929 93978HBT1 2011-06-30 17411441 Refund bonds issued 11/24/2009 0 0 0 Washington Health Care Facilities Authority 911108929 93978HBT1 2011-06-30 5580783 Refund bonds issued 11/24/2009 0 0 0 0 0 33478278 0 0 0 360562 0 0 0 0 96422 2011 1 0 0 1 0 0 34532776 0 0 0 188417 0 0 0 0 375670 2011 1 0 0 1 0 0 17411441 0 0 0 95000 0 0 0 0 189413 2011 1 0 0 1 0 0 5580783 0 0 0 30450 0 0 0 0 60711 2011 1 0 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 1 Barclays Bank PLC 17.5 0 0 0 0 0 0 1 1 Barclays Bank PLC 17.5 0 0 0 0 0 0 1 1 Barclays Bank PLC 17.5 0 0 0 0 0 Washington Health Care Facilities Authority 911108929 93978HBV6 2011-06-30 352651 Refund bonds issued 11/24/2009 0 0 0 Washington Health Care Facilities Authority 911108929 93978HBV6 2011-06-30 84147349 See Part V. 0 0 0 0 0 352651 0 0 0 847 927 0 0 0 3990 2011 1 0 0 1 0 0 84147349 0 0 0 202019 221089 0 37037809 0 46686432 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 1 0 1 1 Barclays Bank PLC 20.5 0 0 0 0 0 0 1 1 Barclays Bank PLC 20.5 0 0 0 0 0 Jean McDougall See Part V. 14210 See Part V. 0 Becton Dickenson See Part V. 2667109 See Part V. 0 Becton Dickenson See Part V. 1910003 See Part V. 0 Ikaria See Part V. 512264 See Part V. 0 SchL_P04_S00_L00 Schedule L, Part IV 1(a) Jean McDougall; (b) Daughter of Officer; (d) Compensation paid to interested person. 2(a) Becton Dickenson; (b) The spouse of B. Trask, who was an officer of the organization; (d) Research support received from interested person. 3(a) Becton Dickenson; (b) The spouse of B. Trask, who was an officer of the organization; (d) Medical supplies purchased from interested person. 4(a) Ikaria, (b) R. Nelson, organization trustee is a director of Ikaria; (d) Research support received from interested person. X 56 6408528 Market Value X Equipment 1 33300 Market Value X Freight Delivery 1 330 Market Value 0 0 1 SchM_P01_S00_L00 Schedule M, Part I Column (b): Organization is reporting the number of contributions. SchM_P01_S00_L32b Schedule M, Part I, Line 32b The Center employs KMS Financial Services to sell securities received as contributions. F990_P06_S0B_L00 Form 990, Part VI, Section B Line 11A - Under the Center's bylaws, the Finance Committee is responsible for reviewing and investigating financial transactions of FHCRC including responsibility of internal and external auditing and for making recommendations to the Board concerning these matters. FHCRC's Vice President of Finance & Chief Financial Officer and his staff work closely with the outside accounting firm FHCRC engages to review the Form 990. The draft of the Form 990 is also reviewed by the Corporate Treasurer, the Executive Vice President & Chief Operating Officer and the Vice President & General Counsel prior to providing it to the Finance Committee. The Finance Committee consults with the Chief Operating Officer, Chief Financial Officer, General Counsel and Corporate Treasurer and such other persons as the Finance Committee may designate to review the draft Form 990. Subsequent to its review, the Finance Committee reports to the Board regarding its oversight of the Form 990. The final draft is provided to the full Board prior to filing the return. F990_P06_S0B_L11b Form 990, Part VI, Section B, Line 11b The final draft is provided to the full Board prior to filing the return. F990_P06_S0B_L12c Form 990, Part VI, Section B, Line 12c The Executive Committee of the Board is responsible for monitoring conflicts of interest involving trustees or the president & Director of the Center. The President & Director of the Center is responsible for monitoring conflict of interest involving other officers, scientific staff and other key personnel designated by the President & Director. Under the FHCRC Conflict of Interest Policy and the related Guidelines, an annual conflict of interest disclosure document aimed at determining family and business relationships and transactions that constitute a conflict of interest under the policy, is distributed to and must be completed by all covered persons. Dislosures by trustees and the President & Director are reviewed by the Office of the General Counsel who reports any conflicts to the Executive Committee with recommendations on appropriate terms for a conflict management plan. Conflict management plans for trustees ot the President & Director are reviewed and approved by the Executive Committee and signed by the person with the conflict of interest and the Chair of the Board. Disclosure by members of the scientific staff, officers other than the President & Director and other key personnel designated by the President & Director are reviewed by the Office of the President & Dierctor, the Office of the General Counsel, and the Director of the division in which the person has his or her primary appointment or responsibilities. If a conflict is determined to exist under the policy a written conflict management plan is recommended by the Office of the General Counsel and approved and signed by the Office of the Director, the Office of the General Counsel and the Division Director as well as the person who has the conflict. Conflict management plans are designated to manage, reduce or eliminate conflicts to prevent bias, improper influence, or misuse of FHCRC or government resources. The conflict management plans for trustees usually require the affected trustee to recuse himself or herself from voting on any matters involving the affected transaction or relationship although he or she is allowed to provide factual information if requested by the Board of Executive COmmittee. All transactions requiring Board or committee approval must be approved by a majority of disinterested persons. Conflict management plans involving scientific staff, officer or other key personnel usually impose one of more of the following conditions or restrictions: i) publid disclosure of the interest; ii) monitoring of research by independent reviewers; iii) modification of the research plan; iv) disqualification from participation in all of or a portion of the research by the person with the conflict of interest; v) divesture of the interest; vi) severance of the relationship creating the conflict of interest. F990_P06_S0B_L15 Form 990, Part VI, Section B, Line 15 Compemsation for the President & Director is determined and approved by the Board Compensation Committee. The compensation of other officers and key personnel at FHCRC is determined by the President & Director subject to ratification by the Compensation Committee. The Compensation Committee has developed, consistent with the organization's philosophy and principles, guidelines for determining compensation and benefits. The Compensation Committee also hires a qualified independent compensation specialist ("independent expert") to review, analyze and provide benchmarking data for the total compensation packages of all officers and key employees. Appropriate comparability data is obtained from the independent expert. No person with a conflict of interest may participate in determining or approving any executive compensation. Meetings of the Compensation Committee are documented in minutes which are approved at the next committee meeting. The above process was last undertaken in 2010 and updated in 2011 for the following positions: Sr VP & Dir, Clin Res Div; VP Shared Resources; Sr VP & Dir, Basic Sci; Sr VP & Co-Dir, VIDD; VP External Affairs & Comm; Sr VP & Deputy Dir, FHCRC; President & Director; VP & Chief Financial Officer; VP Industry Rel & Tech Transfer; VP Human Resources; Sr VP & Dir, PHS; VP Information Technology; Sr VP & Dir, Basic Sci; VP Operations & Facilities; VP General Counsel; Exec VP & COO; Sr VP & Dir, Human Biology; and VP & Dir, Development. F990_P06_S0C_L19 Form 990, Part VI, Section C, Line 19 While federal tax laws do not mandate that the organization's governing documents, Conflict of Interest Policy and financial statements be made available for public inspection, the organization makes these documents available upon request. F990_P11_S00_L05 Form 990, Part XI, Line 5 $10,316,186 = Change in net unrealized gains and losses in fair value of investment; $2,816,994 = Change in value of split-interest agreements; $2,494,930 = Change in net unrealized fair value of swap instruments. Total is $15,628,110. Seattle Vaccine Research Fund 1100 Fairview Ave North Seattle WA 98109 331111221 See Part VII. WA 501(c)(3) 11a N/A UPCID Ltd Upper Mulago Hill Road Kampala UG See Part VII UG See Part VII N/A See Part VII 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 UPCID Ltd b 359000 Cash Transaction UPCID Ltd n 54000 Cash Transaction SchR_P02_S00_L00 Schedule R, Part II Primary activity of Seattle Vaccine Research Fund: Anti-retrovital therapy for eligible participants. Address of UPCID: c/o Uganda Cancer Institute, POB 3935, Mulago Hospital, Upper Mulago Hill Road, Kampala, Uganda. Primary activity of UPCID, Ltd: Research and education regarding cancer and infectious diseases. Exempt Code section for UPCID, Ltd: Uganda Income Tax Act CAP 340, Section 2(bb). Direct controlling entity for UPCID, Ltd: Fred Hutchinson Cancer Research Center.